Is refractory hypotension in preterm infants a manifestation of early ductal shunting?
Sarkar S; Dechert R; Schumacher RE; Donn SM Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Michigan Health System, C.S. Mott Children’s Hospital, Ann Arbor, MI 48109-0254, USA. subratas@med.umich.edu BACKGROUND: Clinicians frequently use hydrocortisone (HC) to treat vasopressor-resistant hypotension even before establishing its cause. OBJECTIVE: To identify the etiologic factors leading to development of refractory hypotension, and to assess if patent ductus arteriosus (PDA) is associated with refractory hypotension during the first week of life.
